A number of pharmacological targets are exploited to modify the parameters in the
Goldmann equation and reduce the intraocular pressure (IOP). This strategy constitutes the …

There was a time gap of over 40 years between the demonstrated oral effectiveness of
acetazolamide in lowering the intraocular pressure (IOP) of glaucoma patients and the …

purpose. There is evidence that altered optic nerve head (ONH) blood flow may play a role
in the development and progression of glaucoma. In the present study, the baseline …

The main objective of this report is to encourage consistent quality of testing and reporting
within and between centres that use colour Doppler imaging (CDI) for assessment of …

Glaucoma is a degenerative optic neuropathy characterized by retinal ganglion cell (RGC)
loss and visual field defects. It is known that in some glaucoma patients, death of RGCs …

Purpose.: To investigate the relationship between clinical factors including 24-hour mean
ocular perfusion pressure (MOPP, ⅔× mean arterial pressure [MAP]− intraocular pressure …

Purpose: To assess the value of colour Doppler imaging (CDI) of the ophthalmic artery (OA)
and short posterior ciliary arteries (SPCAs) in prognosis of disease progression in patients …

Glaucoma, a progressive optic neuropathy characterized by retinal ganglion cell
degeneration and visual field loss, is the leading cause of irreversible blindness worldwide …

Based on the body of evidence implicating ocular blood flow disturbances in the
pathogenesis of glaucoma, there is great interest in the investigation of the effects of …

OBJECTIVES: The European Glaucoma Prevention Study seeks to evaluate the efficacy of
reducing intraocular pressure (IOP), with dorzolamide to prevent or delay patients affected …